Becton, Dickinson and Company · Class II · Cleared Jul 25, 2014
| K-number | K141311 |
| Device name | 0.9% SODIUM CHLORIDE INJECTION, USP BD POSIFLUSH; SP SYRINGE, SF SYRINGE |
| Applicant | Becton, Dickinson and Company |
| Product code | NGT |
| Device class | Class II |
| Decision date | Jul 25, 2014 |
| Decision | Substantially Equivalent |
| Regulation | 880.5200 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov